Invivyd, Inc. Announces 2024 Annual Meeting of Stockholders
Ticker: IVVD · Form: DEF 14A · Filed: Apr 18, 2024 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | DEF 14A |
| Filed Date | Apr 18, 2024 |
| Risk Level | |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Director Election, Auditor Ratification, Invivyd
TL;DR
<b>Invivyd, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on May 21, 2024, to elect directors and ratify the appointment of its auditor.</b>
AI Summary
Invivyd, Inc. (IVVD) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. Invivyd, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 21, 2024, at 8:30 a.m. ET. The meeting will include the election of seven director nominees for one-year terms. Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for FY2024. The Board of Directors recommends voting FOR all director nominees and FOR the ratification of the auditor. The meeting will be conducted via live webcast at www.virtualshareholdermeeting.com/IVVD2024.
Why It Matters
For investors and stakeholders tracking Invivyd, Inc., this filing contains several important signals. This filing is a proxy statement, indicating key corporate governance decisions are being presented to shareholders for a vote. The virtual format for the annual meeting may impact shareholder participation and engagement compared to in-person meetings.
Risk Assessment
Risk Level: — Invivyd, Inc. shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting with standard proposals, posing no immediate significant risk.
Analyst Insight
Review the director nominees and the ratification of the auditor to make informed voting decisions before the May 21, 2024, Annual Meeting.
Key Numbers
- 7 — Director Nominees (Number of nominees for director to be elected.)
- 1-year — Director Term (Duration of the term for elected directors.)
- 2024 — Fiscal Year (Fiscal year for which PricewaterhouseCoopers LLP is proposed as auditor.)
Key Players & Entities
- Invivyd, Inc. (company) — Registrant and filer of the proxy statement.
- PricewaterhouseCoopers LLP (company) — Proposed independent registered public accounting firm.
- May 21, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders.
- 2025 Annual Meeting of Stockholders (date) — Term expiration for elected directors.
FAQ
When did Invivyd, Inc. file this DEF 14A?
Invivyd, Inc. filed this Proxy Statement (DEF 14A) with the SEC on April 18, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Invivyd, Inc. (IVVD).
Where can I read the original DEF 14A filing from Invivyd, Inc.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Invivyd, Inc..
What are the key takeaways from Invivyd, Inc.'s DEF 14A?
Invivyd, Inc. filed this DEF 14A on April 18, 2024. Key takeaways: Invivyd, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on May 21, 2024, at 8:30 a.m. ET.. The meeting will include the election of seven director nominees for one-year terms.. Stockholders will also vote to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for FY2024..
Is Invivyd, Inc. a risky investment based on this filing?
Based on this DEF 14A, Invivyd, Inc. presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting with standard proposals, posing no immediate significant risk.
What should investors do after reading Invivyd, Inc.'s DEF 14A?
Review the director nominees and the ratification of the auditor to make informed voting decisions before the May 21, 2024, Annual Meeting. The overall sentiment from this filing is neutral.
How does Invivyd, Inc. compare to its industry peers?
Invivyd, Inc. operates in the biotechnology sector, focusing on the development of therapeutics.
Are there regulatory concerns for Invivyd, Inc.?
The filing adheres to Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.
Risk Factors
- Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC rules and regulations regarding proxy solicitations and annual meetings.
- Virtual Meeting Logistics [low — operational]: Ensuring a smooth and accessible virtual meeting experience for all stockholders is crucial for engagement.
Industry Context
Invivyd, Inc. operates in the biotechnology sector, focusing on the development of therapeutics.
Regulatory Implications
The filing adheres to Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.
What Investors Should Do
- Review the list of director nominees and their qualifications.
- Understand the role and appointment of PricewaterhouseCoopers LLP as the independent auditor.
- Access the virtual meeting link and control number to participate and vote on May 21, 2024.
Key Dates
- 2024-05-21: 2024 Annual Meeting of Stockholders — Key date for shareholder voting on directors and auditor.
Glossary
- DEF 14A
- Definitive Proxy Statement filed with the SEC. (This is the form type filed, indicating it contains information for shareholder voting.)
- Proxy Statement
- A document that the SEC requires companies to provide to shareholders before their annual meeting. (Contains details on matters to be voted on, including director nominees and auditor appointments.)
Year-Over-Year Comparison
This is the initial filing for the 2024 proxy statement, providing details for the upcoming annual meeting.
Filing Stats: 4,779 words · 19 min read · ~16 pages · Grade level 11.4 · Accepted 2024-04-18 16:06:30
Filing Documents
- ivvd-2024-proxy-def14a.htm (DEF 14A) — 784KB
- img157477811_0.jpg (GRAPHIC) — 84KB
- img157477811_1.jpg (GRAPHIC) — 72KB
- img157477811_2.jpg (GRAPHIC) — 37KB
- img157477811_3.jpg (GRAPHIC) — 8KB
- img157477811_4.jpg (GRAPHIC) — 29KB
- img157477811_5.jpg (GRAPHIC) — 29KB
- img157477811_6.jpg (GRAPHIC) — 72KB
- img157477811_7.jpg (GRAPHIC) — 439KB
- img157477811_8.jpg (GRAPHIC) — 175KB
- 0000950170-24-045549.txt ( ) — 2084KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 21
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 24 Summary Compensation Table 24 Narrative To Summary Compensation Table 24 Annual Base Salary 25 Non-Equity Incentive Plan Compensation 25 Equity-Based Awards 26 Outstanding Equity Awards as of December 31, 2023 26 Retirement Benefits and Other Compensation 27 Employment Agreements with David Hering, M.B.A., Jill Andersen, J.D. and Robert Allen, Ph.D. 27 Potential Payments Upon Termination or Change in Control 27 DIRECTOR COMPENSATION 29 Narrative to Director Compensation Table 29 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 31 TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION 32 Related Person Transactions Policy and Procedures 32 Certain Related Person Transactions 32 Agreements with PHP 32 Mithril Expense Reimbursement 33 Agreements with Adimab 34 Investors’ Rights Agreement 36 Indemnification 36 DEADLINE FOR SUBMISSION OF STOCKHOLDER PROPOSALS FOR 2025 ANNUAL MEETING 37 DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS 38 i Table of Contents QUESTIONS AND ANSWERS ABOUT THES E PROXY MATERIALS AND VOTING The information provided in the “question and answer” format below is for your convenience only and is merely a summary of the information contained in this Proxy Statement. You should read this entire Proxy Statement carefully. Q: What am I being asked to vote on? A: There are two matters scheduled for a vote at the Annual Meeting, which are described in more detail below in this Proxy Statement: • Proposal No. 1 : Election of the seven nominees for director named in this Proxy Statement for a one-year term expiring at the 2025 Annual Meeting (“Proposal No. 1”); and • Proposal No. 2 : Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2